• Report details
  • 10 Figures
  • 9 Tables
  • Market Analysis: Clinical Chemistry
    • Overview of Clinical Chemistry Market
    • Market Outlook
      • Major Product Activity
    • Regional Market
    • Top Company Briefs
      • Roche
      • Abbott
      • Danaher
  • Executive News Briefing
    • Cue Health Calls It Quits
    • Allez Health Secures $60 Million in Funding
    • Next Gen Diagnostics Welcomes New Scientific Advisory Board Member
    • Next Gen Diagnostics Opens First U.S. Laboratory
  • Financial Highlights: bioMérieux & Sekisui Diagnostics
  • Diagnostic Market Mergers, Acquisitions and Partnership Deals
    • Mergers and Acquisitions
    • Partnerships and Collaborations
  • Industry Watch
    • COVID-19/Flu Update
  • Region Watch
  • Broad-based Company Announcements
    • Announcements
      • QIAGEN Launches Gastrointestinal Molecular Panel in the United States
      • Illumina Spins Off Grail
      • QIAGEN Discontinues NeuMoDx System
      • DiaSorin Nabs Clearance for LIAISON PLEX Blood Culture Yeast Assay
      • Genetic Signatures Granted FDA Clearance for GI Kit
Attachments
In Vitro Diagnostics Business Outlook, Volume 3, Issue 3 - Clinical Chemistry
4 Jul 2024

GSL

Request Access

In Vitro Diagnostics Business Outlook is a bimonthly publication with six issues annually.

In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including: ​

  • Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities​
  • A comprehensive view of the IVD market with test categories covered and company briefs​
  • M&A activities, selected partnerships & collaborations, partnership deals, and more
  • Industry & region watch to help tailor strategies​
  • Analysis of news and events and reporting on news not easily available ​
 
Page Count: 35
Table of Contents
  • Market Analysis: Clinical Chemistry
    • Overview of Clinical Chemistry Market
    • Market Outlook
      • Major Product Activity
    • Regional Market
    • Top Company Briefs
      • Roche
      • Abbott
      • Danaher
  • Executive News Briefing
    • Cue Health Calls It Quits
    • Allez Health Secures $60 Million in Funding
    • Next Gen Diagnostics Welcomes New Scientific Advisory Board Member
    • Next Gen Diagnostics Opens First U.S. Laboratory
  • Financial Highlights: bioMérieux & Sekisui Diagnostics
  • Diagnostic Market Mergers, Acquisitions and Partnership Deals
    • Mergers and Acquisitions
    • Partnerships and Collaborations
  • Industry Watch
    • COVID-19/Flu Update
  • Region Watch
  • Broad-based Company Announcements
    • Announcements
      • QIAGEN Launches Gastrointestinal Molecular Panel in the United States
      • Illumina Spins Off Grail
      • QIAGEN Discontinues NeuMoDx System
      • DiaSorin Nabs Clearance for LIAISON PLEX Blood Culture Yeast Assay
      • Genetic Signatures Granted FDA Clearance for GI Kit
Categories
To the Top
More information about this product
Table of Contents
Other Users Also Viewed
In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028
22 Sep 2023
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama Information’s In Vitro…
SDi Global Assessment Report 2020: The Laboratory Analytical & Life Science Instrumentation Industry
24 Jun 2020
The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition
24 Aug 2023
The Worldwide Market for In Vitro Diagnostic Tests, 15th Edition
25 Aug 2022
Kalorama Information's Molecular Diagnostics Quarterly Datastream
31 Dec 2022